Visirose

Vision is humanity’s most treasured sense. Yet for countless people worldwide, the scourge of eye infection and disease has stolen this precious faculty of sight, cloaking them in shadows, discomfort, and often perpetual darkness. VisiRose is pioneering a global revolution to protect and restore vision. Through invention, science, and technology, VisiRose is committed to reclaiming what has been lost, offering the transformative gift of renewed sight. VisiRose is a clinical-stage biotechnology company of the University of Miami and Provectus Biopharmaceuticals, focused on commercializing the Miller School of Medicine’s Bascom Palmer Eye Institute and its Ophthalmic Biophysics Center’s innovative ocular research using bioactive synthetic small molecule rose bengal. VisiRose is transforming lives through the restoration of vision.